Papaverine 150 mg / Phentolamine 5 mg vials recalled over sterility concerns
- Recall date
- July 26, 2016
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Pharmacy Plus, Inc. dba Vital Care Compounder recalls Papaverine 150 mg / Phentolamine 5 mg vials, packaged 5.5 mL in a sterile, clear 10 mL MDV, Rx only, Sterile Injection,…
- Recall number
- D-1534-2016
- FDA classification
- Class II
- Brand / firm
- Pharmacy Plus, Inc. dba Vital Care Compounder
- Sold / distributed
- MS
Why it was recalled
Lack of Assurance of Sterility
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Papaverine 150 mg / Phentolamine 5 mg vials, packaged 5.5 mL in a sterile, clear 10 mL MDV, Rx only, Sterile Injection, Vital Care Compounder, Hattiesburg, MS 39402
Get recall alerts
Free email alert whenever Pharmacy Plus, Inc. dba Vital Care Compounder has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Pharmacy Plus, Inc. dba Vital Care Compounder